Millendo Therapeutics develops           novel, disease-modifying treatments         for endocrine diseases caused by   hormone dysregulation.

Learn More

April 14, 2016
Millendo Therapeutics Expands Management Team with Addition of Two Vice Presidents
Read More >>

March 18, 2016
Millendo Therapeutics Announces Publication of Preclinical Data for ATR-101 and Data Presentations at ENDO 2016
Read More >>